QIAGEN Clinical Insight surpasses 1 million patient test cases analyzed and interpreted

QIAGEN and McKesson agree to distribute QIAstat-Dx syndromic testing solution to smaller hospitals and other select segments in the United States

QIAGEN to deliver genomic insights for Japan’s new molecular oncology clinical research and precision medicine initiative

QIAGEN to embrace global initiative to combat antibiotic resistance and launches cutting-edge QIAGEN Microbial Insights AR

QIAGEN launches novel NGS panel for rare and inherited diseases with advanced bioinformatics for complete Sample to Insight solution

QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer

QIAGEN and U.K. alliance launch APIS Assay Technologies to expand biomarker research and foster healthcare innovation

QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation

QIAGEN gains 510(k) clearance by FDA for QIAstat-Dx in the U.S. and launches system as next generation platform for syndromic insights